Accessibility Menu
Icon Public logo

Icon Public(NASDAQ) ICLR

Market Cap$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1998)+2,413%
5 Year-39%
1 Year-10%
1 Month+1%
Premium Feature
Moneyball Superscore
49/100
$163.66
+2.39%
+3.82Today
After hours$163.74+$0.08 (+0.05%)
Icon Public last closing stock price
MetricPriceDate
Last closeUSD 159.842026-09-02
Icon Public stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.38%USD 168.932026-08-26
1 month+0.9%USD 158.412026-08-03
3 month+4.61%USD 152.802026-06-04
Year to date-12.28%USD 182.222025-12-31
1 year-10.12%USD 177.842025-09-02
3 year-39.15%USD 262.692023-09-01
5 year-39.08%USD 262.362021-09-03
Since inception+2,413.41%USD 6.361998-05-15

Icon Public Financials at a Glance

Market Cap

$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.25B

Net Income (TTM)

$328.88M

EPS (TTM)

$0.55

P/E Ratio

290.14

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Price

$163.66

Volume

594,039.856

Open

$159.87

Previous Close

$163.58

Daily Range

$159.55 - $164.35

52-Week Range

$66.57 - $203.91

Estimated Earnings Date

Oct 28, 2026

ICLR News

Person in a lab gazing into a microscope

Why Icon Stock Crushed it on Wednesday

Eric VolkmanJun 24, 2026
Institutional.png

LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million

Johnny RiceJul 8, 2025
scientist sterilizing test tubes lab science

2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch

James HalleyMar 25, 2023
GettyImages-159757472

Why PRA Health Sciences Stock Is Soaring Today

Prosper Junior BakinyFeb 24, 2021
20190123_IF_Healthcare_thumb_02

Why Contract Research Organizations Can Be Money-Making Machines for Investors

Motley Fool StaffJan 25, 2019
take-long-view_large

Why ICON PLC Stock Soared Today

Brian FeroldiJul 28, 2015
ryanair-aircraft-(2)

5 Top Stocks to Own If Europe's Economy Recovers

Todd CampbellJan 23, 2015

4 Disruptive Stocks Biotechs Depend On

Todd CampbellMar 28, 2014
Page 1

ICLR: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Icon Public

ICON Public Limited Company is a leading clinical research organization that provides outsourced development and commercialization services globally. The company specializes in managing and analyzing clinical development programs across various stages, from compound selection to Phase I-IV clinical studies.

Products and Services
  • Comprehensive clinical development services across all phases
  • Laboratory services including biomanalytical and central laboratory services
  • Consulting and advisory services for clinical trial management
Growth Outlook
  • Revenue of $2.06 billion in Q2 2026, showing consistent growth
  • Net income of $72.58 million in Q2 2026, reflecting strong operational efficiency
  • Strategic alliances enhancing service offerings and market reach
Financial Highlights
  • Trailing twelve months (TTM) revenue of $8.23 billion, indicating robust demand
  • Operating income margin of 9.41% in Q2 2026, showcasing effective cost management
  • Cash flow from operations of $277.53 million in Q2 2026, supporting financial stability
ICON Public Limited Company operates in the healthcare sector, primarily serving pharmaceutical, biotechnology, and medical device industries. The company has demonstrated a strong financial performance, with a TTM revenue of $8.23 billion, reflecting a solid demand for its services. The recent quarterly results indicate a revenue of $2.06 billion in Q2 2026, alongside a net income of $72.58 million, which underscores the company's operational efficiency and ability to manage costs effectively. The company's strategic alliances, such as the partnership with Advarra, Inc., enhance its service offerings and expand its market reach. This positions ICON favorably for future growth, as it continues to adapt to the evolving needs of the clinical research landscape. With a focus on comprehensive clinical development services and a commitment to innovation, ICON Public Limited Company remains a significant player in the medical diagnostics and research industry.
AI Generated • Aug 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

40,100

CEO

Barry Balfe

Website

www.iconplc.com

Headquarters

Dublin, DU D18 X5R3, IE

ICLR Financials

Key Financial Metrics (TTM)

Gross Margin

21.85%

Operating Margin

10.15%

Net Income Margin

3.99%

Return on Equity

3.54%

Return on Capital

7.94%

Return on Assets

2.01%

Earnings Yield

0.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

77.15M

Volume

594.04K

Avg. Volume

839.40K

Financials (TTM)

Gross Profit

$1.80B

Operating Income

$837.60M

EBITDA

$1.25B

Operating Cash Flow

$1.62B

Capital Expenditure

-$274.89M

Free Cash Flow

$1.35B

Cash & ST Invst.

$928.38M

Total Debt

$3.49B

Icon Public Performance Analysis

Icon Public annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,741,386,00041.2%
20232023-12-31USD 8,120,176,0004.9%
20242024-12-31USD 8,188,990,0000.8%
20252025-12-31USD 8,251,340,0000.8%
Icon Public sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.3%
Q42025-12-313.4%
Q12026-03-31-3.7%
Q22026-06-301.4%
Icon Public annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 6.13172.3%
20232023-12-31USD 7.4020.8%
20242024-12-31USD 8.9020.2%
20252025-12-31USD 2.90-67.4%
Icon Public sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-98.7%
Q42025-12-316290.7%
Q12026-03-31-29.5%
Q22026-06-30-30.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.06B

+2.3%

Gross Profit

$388.53M

-30.8%

Gross Margin

18.83%

N/A

Market Cap

$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$306.77K

N/A

Employees

40,200

N/A

Net Income

$72.58M

-60.3%

EBITDA

$293.88M

-4.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$928.38M

+137.8%

Total Debt

$3.49B

-1.5%

Accounts Receivable

$2.71B

-2.5%

Inventory

$0.00

N/A

Long Term Debt

$2.21B

-37.1%

Short Term Debt

$1.28B

+4200.0%

Return on Assets

2.01%

N/A

Return on Invested Capital

6.72%

N/A

Free Cash Flow

$235.34M

+84.5%

Operating Cash Flow

$277.53M

+71.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EHCEncompass Health Corporation
$122.59+1.16%
COOThe Cooper Companies, Inc.
$70.64+1.31%
UHSUniversal Health Services, Inc.
$169.21+1.03%
RVTYRevvity, Inc.
$130.63-0.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About ICLR

What is the current price of Icon Public?

Icon Public is trading at $163.58 per share.

What is the 52-week range for Icon Public?

Over the past 52 weeks, Icon Public has traded between $66.57 and $203.91.

How much debt does Icon Public have?

As of the most recent reporting period, Icon Public reported total debt of $3.53B.

How much cash does Icon Public have on hand?

Icon Public reported $928.39M in cash and cash equivalents in its most recent financial results.

What is Icon Public’s dividend yield?

Icon Public does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services